NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
Back to search
Official data from USPTO
MANUKA PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MANUKA PHARM
ST13
US500000098112891Class
41, 44
Filing
98112891
Registration
7725756
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/11/2025
Trademark type
Word
Nice classes
41, 44
Filing date
08/02/2023
Registration date
03/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
03/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use, Foreign priority
First use anywhere
11/23/2018
First use in commerce
11/23/2018
Drawing code
4
Owner type
24
Owner location
Auckland, NZ
Examiner
ROACH, APRIL K
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Manuka Doctor Limited
Representatives
Anna Kurian Shaw Hogan Lovells US LLP
Technical classification
Nice Classes
Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Online publication of blogs; on-line journalsblogs featuring information concerning Manuka honey production and consumption
Class 44
Providing medical information; providing medical information concerning the medicinal effects of Manuka honey consumption; providing information about beekeeping and honey productioninformation about harvesting of Manuka honey for others
Publications
History of USPTO decisions and trademark events.
33 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/11/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/18/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/18/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/18/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/18/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/18/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/18/2025
IUAA
USE AMENDMENT ACCEPTED
02/03/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/30/2025
IUAF
USE AMENDMENT FILED
01/30/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/30/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2025
GNRT
NON-FINAL ACTION E-MAILED
01/08/2025
CNRT
NON-FINAL ACTION WRITTEN
01/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/07/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/26/2024
GNSL
LETTER OF SUSPENSION E-MAILED
11/26/2024
CNSL
SUSPENSION LETTER WRITTEN
11/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2024
ALIE
ASSIGNED TO LIE
11/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2024
GNRT
NON-FINAL ACTION E-MAILED
04/04/2024
CNRT
NON-FINAL ACTION WRITTEN
04/04/2024
DOCK
ASSIGNED TO EXAMINER
04/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2023
NWAP
NEW APPLICATION ENTERED
08/05/2023
Continuous trademark protection
Get notified about every new filing that threatens MANUKA PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.